FDA Center for Drug Evaluation & Research Issues Warning Letter to Gopaldas Visram & Co.
June 11, 2026
June 11, 2026
WASHINGTON, June 11 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Gopaldas Visram & Co. Ltd. from its Center for Drug Evaluation and Research:
* * *
Recipient: Mr. Mukund V. Thakker, Director, Gopaldas Visram & Co., Ltd., Plot No. A /327, TTC Industrial Area, M.I.D.C., Mahape Navi Mumbai 400710, Maharashtra, India
Issuing Office: Center for Drug Evaluation and Research (CDER), . . .
* * *
Recipient: Mr. Mukund V. Thakker, Director, Gopaldas Visram & Co., Ltd., Plot No. A /327, TTC Industrial Area, M.I.D.C., Mahape Navi Mumbai 400710, Maharashtra, India
Issuing Office: Center for Drug Evaluation and Research (CDER), . . .